Donald K. Baker
- Pharmacology top 0.5%
- Pediatrics, Perinatology and Child Health top 2%
- Oncology top 10%
- Genetics top 10%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- James M. HoffmanMary V. RellingKristine R. CrewsScott C. HowardWilliam E. EvansCyrine E. HaidarUlrich BroeckelNancy M. Kornegay
- Topics
- Pharmacogenetics and Drug Metabolism (6 papers)Antibiotics Pharmacokinetics and Efficacy (6 papers)Pharmaceutical studies and practices (6 papers)
- Partner nations
- United StatesCzechiaGermany
In The Last Decade
Donald K. Baker
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 117
- Pharmacology 461
- Pediatrics, Perinatology and Child Health 445
- Oncology 240
- Genetics 230
- Public Health, Environmental and Occupational Health 151
Countries citing papers authored by Donald K. Baker
This map shows the geographic impact of Donald K. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald K. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald K. Baker more than expected).
Fields of papers citing papers by Donald K. Baker
This network shows the impact of papers produced by Donald K. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald K. Baker. The network helps show where Donald K. Baker may publish in the future.
Co-authorship network of co-authors of Donald K. Baker
This figure shows the co-authorship network connecting the top 25 collaborators of Donald K. Baker. A scholar is included among the top collaborators of Donald K. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald K. Baker. Donald K. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 6 | |
| 3 | 11 | |
| 4 | 4 | |
| 5 | 56 | |
| 6 | 32 | |
| 7 | 205 | |
| 8 | 22 | |
| 9 | 159 | |
| 10 | 77 | |
| 11 | 26 | |
| 12 | 65 | |
| 13 | 42 | |
| 14 | 18 | |
| 15 | 50 | |
| 16 | 42 | |
| 17 | 2 | |
| 18 | 144 | |
| 19 | 6 | |
| 20 | 22 |
About Donald K. Baker
Donald K. Baker is a scholar working on Health Information Management, Geriatrics and Gerontology and Emergency Medical Services, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmaceutical studies and practices (6 papers). The work is most often cited by research in Pharmacology (461 citations), Geriatrics and Gerontology (97 citations) and Pediatrics, Perinatology and Child Health (445 citations). Donald K. Baker has collaborated with scholars based in United States, Czechia and Germany. Frequent co-authors include James M. Hoffman, Mary V. Relling, Kristine R. Crews, Scott C. Howard, William E. Evans, Cyrine E. Haidar, Ulrich Broeckel, Nancy M. Kornegay, Shane J. Cross and Mark R. Wilkinson. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Geochimica et Cosmochimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.